Researchers sought to investigate the genetic overlap between inflammatory bowel disease and Parkinson disease via advanced genomic analysis techniques.

The CIFFREO study enrolled ambulatory male participants 4 to 7 years of age with a confirmed diagnosis of DMD.

The generic product is being made available by Cranbury Pharmaceuticals.

Neurodevelopmental assessments at corrected age of 3 to 4 months can reliably predict cerebral palsy and its severity.

In a phase 3 study, researchers assessed the safety and efficacy of a 24-hour subcutaneous levodopa-carbidopa solution compared with oral immediate-release levodopa-carbidopa for motor fluctuations in patients with Parkinson disease.

Researchers are conducting a double-blind, randomized controlled trial to demonstrate the efficacy of specialized phototherapy for the treatment of Parkinson disease.

In a phase 2, double-blind, randomized, placebo-controlled trial, researchers assessed the effect of lixisenatide on the progression of motor disability in patients with Parkinson disease.

In a subgroup analysis of a phase 3, randomized, double-blind, active-controlled study, researchers compared the efficacy of subcutaneous LDP/CDP with oral LD/CD across subgroups of patients with advanced PD.

Researchers examined the relationship between exposure to anti-inflammatory therapy and the incidence of Parkinson disease in patients with autoimmune conditions.

Researchers explored the relationship between military service and amyotrophic lateral sclerosis survival in the context of occupational lead exposure.

In a population-based, case-control study, researchers assessed the relationship between environmental exposure to airborne metals and Parkinson disease risk.

The drug/device combination therapy provides a continuous subcutaneous infusion of apomorphine through an infusion pump.

In a cross-sectional study, researchers determined the positivity rate of phosphorylated α-synuclein deposition via skin biopsy in patients with Parkinson disease, dementia with Lewy bodies, multiple system atrophy, and pure autonomic failure.

Researchers explored the relationship between intra-articular mineralization and cartilage worsening over 2 years among older patients with or at risk for osteoarthritis.

Researchers sought assess the prevalence and incidence of, and the annual rates of conversion to, mild cognitive impairment and dementia in patients with essential tremor.

In a systematic review, researchers analyzed qualitative and quantitative evidence of PD motor and nonmotor symptoms affecting HRQoL in patients with PD and their caregivers.

Researchers explored whether initiation of antidepressants among Parkinson patients is associated with the emergence of impulse control disorder.

The US FDA grants approval to Medtronic’s rechargeable deep brain stimulation device, Percept RC Deep Brain Stimulation (DBS) system.

In a retrospective analysis, researchers assessed simultaneous or sequential advanced therapy combinations in patients with PD at the start of the initiation of second advanced therapies.

Using population-based US Medicare data, researchers assessed the nationwide geographic relationship between Parkinson disease and air pollution, specifically PM2.5.

Investigators conducted a randomized controlled trial to investigate the efficacy and tolerability of cannabis use in improving Parkinson disease symptoms.

Researchers sought to determine whether palliative care training for community neurologists and access to remote palliative care teams improves outcomes in patients with PDRD.

Researchers sought to assess the association between total cerebrospinal fluid (CSF) protein levels and severity in Parkinson disease.

In a multicenter, double-blind, randomized trial, researchers investigated the efficacy and safety of botulinum toxin injections in patients with isolated and essential head tremor.

In a phase open-label, single-arm study, researchers evaluated the safety, tolerability, and efficacy of 24-hour continuous subcutaneous injection of foslevodopa/foscarbidopa in patients with advanced PD.

In a prospective cohort study, researchers examined whether loneliness is associated with the risk for incident Parkinson disease and whether this association is independent of known genetic, clinical, behavioral, and social risk factors.

Researchers sought to perform a comprehensive genome-wide assessment in African and African admixed individuals to better understand the genetic architecture of PD in these underserved populations.

In case-control and cohort analyses, researchers determined the incidence of gastrointestinal syndromes and interventions preceding Parkinson disease.

In a cross-sectional analysis, researchers assessed inner retinal anatomy in patients with prevalent PD, and subsequently assessed the association of these markers with the development of PD.

An artificial intelligence tool can help remotely assess the severity of Parkinson disease symptoms; not quite as good as expert neurologists